Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term tacrolimus ointment in paediatric atopic dermatitis
2004-001644-80Phase 3Completed
- Sponsor
- Fujisawa Pharmaceutical
- Start
- Aug 2004
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of Envarsus XR in atopic dermatitis (AD) (2 arms), sponsored by Fujisawa Pharmaceutical. Primary endpoint: Number of disease exacerbations requiring substantial therapeutic intervention. Started Aug 2004; status: completed.
02
Drugs
Envarsus XR
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on 2004-001644-80.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-001644-80.